A detailed history of Alliancebernstein L.P. transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 244,576 shares of TERN stock, worth $1.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
244,576
Previous 298,064 17.95%
Holding current value
$1.43 Million
Previous $2.03 Million 0.49%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.49 - $10.8 $347,137 - $577,670
-53,488 Reduced 17.95%
244,576 $2.04 Million
Q2 2024

Aug 14, 2024

BUY
$4.54 - $8.2 $1.27 Million - $2.29 Million
278,854 Added 1451.61%
298,064 $2.03 Million
Q1 2024

May 14, 2024

SELL
$4.86 - $8.19 $32,756 - $55,200
-6,740 Reduced 25.97%
19,210 $126,000
Q3 2023

Nov 14, 2023

BUY
$4.7 - $8.55 $24,581 - $44,716
5,230 Added 25.24%
25,950 $130,000
Q2 2023

Aug 15, 2023

BUY
$7.35 - $13.29 $152,292 - $275,368
20,720 New
20,720 $181,000

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $220M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.